R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Vice President Digital & Technology Solutions Partner - Finance, Accounting & Oracle ERP

Enterprise ApplicationsConfirmed live in the last 24 hours
Full-timeSleepy Hollow, NY, USA$300k - $500k /yr

About the Job

Requirements

  • A BS or BA in Computer Science, Information Systems, Finance, or a related field is required.
  • At least 18 years of progressive technology leadership, including finance systems and enterprise platforms such as Oracle E-Business Suite (EBS) and/or Oracle Fusion. Candidates with extensive SAP FI/CO leadership experience may be considered.
  • A history of successful executive leadership of finance technology, investor relations, facilities and real estate systems, and audit, tax, or treasury platforms.
  • Familiarity with software development lifecycle governance frameworks is a plus.
  • Proven ability to lead at enterprise scale, influence executive stakeholders, negotiate complex matters, and attract top talent.

Responsibilities

  • Set enterprise technology strategy across Finance, Investor Relations, Facilities Management, Audit, Tax, and Treasury, aligning Oracle E-Business Suite (EBS), Fusion, and related platform roadmaps with corporate strategy, operational priorities, and company-wide performance goals.
  • Lead a multi-team technology organization through directors, managers, and a large network of external professionals.
  • Improve business outcomes measured by financial close cycle time, forecast accuracy, working capital visibility, reporting timeliness, controls effectiveness, automation adoption, system reliability, and user productivity across Finance and adjacent corporate functions.
  • Lead Oracle EBS and Fusion platform strategies, including modernization and integration decisions.
  • Own the multi-year transformation roadmap across Finance and G&A systems, prioritizing investments, sequencing modernization initiatives, simplifying legacy complexity, and driving adoption of new digital capabilities.
  • Establish and govern Finance data, analytics, and decision intelligence strategy, including data quality, master data alignment, trusted executive reporting, and analytics capabilities.
  • Drive global operating model and process standardization across regions, legal entities, shared services, and business units, focusing on close, planning, procure-to-pay, treasury, tax, audit, and reporting workflows.
  • Manage strategic vendors, managed services, implementation partners, and technology spend, including partner performance, contract outcomes, portfolio prioritization, and financial discipline.
  • Strengthen resilience and operational risk management for mission-critical finance platforms in partnership with cybersecurity, access governance, disaster recovery, incident response, and business continuity functions.
  • Define and advance the AI strategy and AI agent roadmap for financial operations, identifying automation and decision-support opportunities, strengthening controls, and scaling AI-enabled capabilities across Finance and related corporate functions.
  • Direct more than 1,000 integration points between financial applications and boundary systems.
  • Support systems strategy and delivery capabilities for global financial consolidations, statutory reporting, and operational performance reporting.
  • Own technology systems and controls supporting Audit, Tax, and Treasury, and establish enterprise software development lifecycle standards and governance across Commercial and G&A technology.
  • Ensure SOX-compliant technology operations across in-scope financial systems, including effective controls execution, audit readiness, remediation of control gaps, and strong internal and external audit results.

Desired Qualifications

  • An MBA is preferred.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs